Infection of macaques after vaginal exposure to cell-associated simian immunodeficiency virus

Journal of Infectious Diseases

Volumn 202, Issue 3, 2010, Pages 337-344

  Sallé, Bettina ^a,b,c   Brochard, Patricia ^a,b   Bourry, Olivier ^a,b   Mannioui, Abdelkrim ^a,b   Andrieu, Thibault ^a,b   Prevot, Sophie ^d   Dejucq Rainsford, Nathalie ^e   Dereuddre Bosquet, Nathalie ^a,b   Grand, Roger Le ^a,b  

^a DIF   (France)

^b INSTITUT D'OPTIQUE GRADUATE SCHOOL   (France)

^c CENTRE INTERNATIONAL DE RECHERCHES MÉDICALES DE FRANCEVILLE   (Gabon)

^d HÔPITAL ANTOINE BÉCLÈRE   (France)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; MEDROXYPROGESTERONE ACETATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; FEMALE; FLOW CYTOMETRY; FREEZE THAWING; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFECTION PREVENTION; INOCULATION; LYMPHOID TISSUE; MACACA; NONHUMAN; PRIORITY JOURNAL; SEXUAL TRANSMISSION; SIMIAN IMMUNODEFICIENCY VIRUS; SPLEEN CELL; UTERINE CERVIX MUCOSA; VAGINA MUCOSA; VAGINITIS; VIREMIA; VIRUS INFECTION; VIRUS TRANSMISSION; ANIMAL; DISEASE MODEL; DISEASE TRANSMISSION; MUCOSA; PATHOGENICITY; SEXUALLY TRANSMITTED DISEASE; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SPLEEN; VAGINA; VIROLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOID TISSUE; MACACA; MUCOUS MEMBRANE; SEXUALLY TRANSMITTED DISEASES, VIRAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; SPLEEN; VAGINA;

EID: 77954704777     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/653619     Document Type: Article

References (25)

1. Shattock RJ, Haynes BF, Pulendran B, Flores J, Esparza J. Improving defences at the portal of HIV entry: mucosal and innate immunity. PLoS Med 2008; 5:e81.
2. Shattock RJ, Moore JP. Inhibiting sexual transmission of HIV-1 infection. Nat Rev Microbiol 2003; 1:25-34.
3. Tachet A, Dulioust E, Salmon D, et al. Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission. AIDS 1999; 13:823-831.
4. Mayer KH, Boswell S, Goldstein R, et al. Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy. Clin Infect Dis 1999; 28:1252-1259.
5. Xu C, Politch JA, Tucker L, Mayer KH, Seage GR III, Anderson DJ. Factors associated with increased levels of human immunodeficiency virus type 1 DNA in semen. J Infect Dis 1997; 176:941-947.
6. Coombs RW, Reichelderfer PS, Landay AL. Recent observations on HIV type-1 infection in the genital tract of men and women. AIDS 2003; 17:455-480.
7. Bujan L, Daudin M, Matsuda T, et al. Factors of intermittent HIV-1 excretion in semen and efficiency of sperm processing in obtaining spermatozoa without HIV-1 genomes. AIDS 2004; 18:757-766.
8. Quayle AJ, Xu C, Mayer KH, Anderson DJ. T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen. J Infect Dis 1997; 176:960-968.
9. Le Tortorec A, Le Grand R, Denis H, et al. Infection of semen-producing organs by SIV during the acute and chronic stages of the disease. PLoS ONE 2008; 3:e1792.
10. Karlsson I, Malleret B, Brochard P, et al. Dynamics of T-cell responses and memory T cells during primary simian immunodeficiency virus infection in cynomolgus macaques. J Virol 2007; 81:13456-13468.
11. Benlhassan-Chahour K, Penit C, Dioszeghy V, et al. Kinetics of lymphocyte proliferation during primary immune response in macaques infected with pathogenic simian immunodeficiency virus SIVmac251: preliminary report of the effect of early antiviral therapy. J Virol 2003; 77:12479-12493.
12. Quakkelaar ED, Beaumont T, van Nuenen AC, et al. T cell line passage can select for pre-existing neutralization-sensitive variants from the quasispecies of primary human immunodeficiency virus type-1 isolates. Virology 2007; 359:92-104.
13. York J, Follis KE, Trahey M, Nyambi PN, Zolla-Pazner S, Nunberg JH. Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1. J Virol 2001; 75: 2741-2752.
14. Overbaugh J, Bangham CR. Selection forces and constraints on retroviral sequence variation. Science 2001; 292:1106-1109.
15. Neildez O, Le Grand R, Caufour P, et al. Selective quasispecies transmission after systemic or mucosal exposure of macaques to simian immunodeficiency virus. Virology 1998; 243:12-20.
16. Marx PA, Spira AI, Gettie A, et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med 1996; 2:1084-1089.
17. Spouge JL. Statistical analysis of sparse infection data and its implications for retroviral treatment trials in primates. Proc Natl Acad Sci U S A 1992; 89:7581-7585.
18. Politch JA, Mayer KH, Anderson DJ. Depletion of CD4+ T cells in semen during HIV infection and their restoration following antiretroviral therapy. J Acquir Immune Defic Syndr 2009; 50:283-289.
19. Ibata B, Parr EL, King NJ, Parr MB. Migration of foreign lymphocytes from the mouse vagina into the cervicovaginal mucosa and to the iliac lymph nodes. Biol Reprod 1997; 56:537-543.
20. Di Fabio S, Giannini G, Lapenta C, et al. Vaginal transmission of HIV- 1 in hu-SCID mice: a new model for the evaluation of vaginal microbicides. AIDS 2001; 15:2231-2238.
21. Perotti ME, Pirovano A, Phillips DM. Carrageenan formulation prevents macrophage trafficking from vagina: implications for microbicide development. Biol Reprod 2003; 69:933-939.
22. Zacharopoulos VR, Perotti ME, Phillips DM. A role for cell migration in the sexual transmission of HIV-1? Curr Biol 1997; 7:534-537.
23. Sodora DL, Gettie A, Miller CJ, Marx PA. Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks. AIDS Res Hum Retroviruses 1998; 14(Suppl 1):S119-S123.
24. Kaizu M, Weiler AM, Weisgrau KL, et al. Repeated intravaginal inoculation with cell-associated simian immunodeficiency virus results in persistent infection of nonhuman primates. J Infect Dis 2006; 194: 912-916.
25. Weiler AM, Li Q, Duan L, et al. Genital ulcers facilitate rapid viral entry and dissemination following intravaginal inoculation with cellassociated simian immunodeficiency virus SIVmac239. J Virol 2008; 82:4154-4158.